Search

everythinglearnresearchcommunity

for

Search:↓

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Leptin, a hormone, is important for starting hair growth.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

New therapies for alopecia areata show potential but need more research.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Stress in hair follicle stem cells causes inflammation in a chronic skin condition through a specific immune response pathway.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Natural products show promise for new hair loss treatments.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Genomic research can help improve the quality and production of natural fibers in animals.